Before using this product, it is important to read the entire product insert. The following is an excerpt from the Boxed Warning which highlights important safety information:
RECUVYRA contains fentanyl, a high concentration µ-opioid receptor agonist (50 mg/mL) and is a Class II controlled substance with high potential for abuse.
Risk Minimization and Action Plan:
This product is distributed under a Risk Minimization Action Plan (RiskMAP) and its use is limited to certified veterinarians.
SECONDARY EXPOSURE TO FENTANYL IN CHILDREN AND ADULTS: Strict adherence to the requirements of the RiskMAP and the INSTRUCTIONS FOR USE provided in this product insert is imperative in order to reduce the potential of secondary exposure to fentanyl from RECUVYRA treated skin.
Individual dogs may be especially sensitive to the effects of fentanyl.
See Contraindications, Warnings: Human and Animal Safety, and Precautions for detailed information.